Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
or
Menu

Reshape Lifesciences Inc (RSLS)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ fieldTitles[key] ]] [[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 485
  • Shares Outstanding, K 950
  • Annual Sales, $ 1,290 K
  • Annual Income, $ -33,820 K
  • 36-Month Beta 1.99
  • Price/Sales 0.39
  • Price/Cash Flow N/A
  • Price/Book 0.01
  • Price/Earnings ttm 0.00
  • Earnings Per Share ttm -2,429.31
  • Most Recent Earnings N/A on N/A
  • Next Earnings Date 11/14/18
  • Annual Dividend & Yield 0.00 (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sectors:

Price Performance

See More
Period Period Low Period High Performance
1-Month
0.49 +4.08%
on 12/14/18
2.55 -80.00%
on 11/26/18
-1.32 (-72.13%)
since 11/14/18
3-Month
0.49 +4.08%
on 12/14/18
10.64 -95.21%
on 09/17/18
-8.59 (-94.40%)
since 09/14/18
52-Week
0.49 +4.08%
on 12/14/18
3,759.00 -99.99%
on 01/25/18
-2,792.49 (-99.98%)
since 12/14/17

Most Recent Stories

More News
ReShape Lifesciences Expands International Business in the Middle East

SAN CLEMENTE, CA / ACCESSWIRE / December 6, 2018 / ReShape Lifesciences Inc. (NASDAQ: RSLS), a developer of minimally invasive medical devices to treat obesity and metabolic diseases, today announced that...

RSLS : 0.51 (unch)
ReShape Lifesciences Announces Live Surgery Course for ReShape Vest

SAN CLEMENTE, CA / ACCESSWIRE / December 3, 2018 / ReShape Lifesciences Inc. (NASDAQ: RSLS), a developer of minimally invasive medical devices to treat obesity and metabolic diseases, today announced that...

RSLS : 0.51 (unch)
ReShape Lifesciences Provides Financing and Corporate Update

Closing on Recent Financings Resulting in $25 Million in Gross Proceeds Company Funded to Support Current Operations Into 2020

RSLS : 0.51 (unch)
4 Healthcare Stocks Seeing New Highs On Monday

CORAL GABLES, FL / ACCESSWIRE / November 26, 2018 / remain popular during the latest bout of selling pressure within the broader markets. Despite potential drug-price controls, investors are seeing a...

BIOS : 3.85 (-3.27%)
NVAX : 2.41 (+4.78%)
RSLS : 0.51 (unch)
ReShape Lifesciences Announces $10 Million Registered Direct Offering

SAN CLEMENTE, CA / ACCESSWIRE / November 26, 2018 / ReShape Lifesciences Inc. (NASDAQ: RSLS), a developer of minimally invasive medical devices to treat obesity and metabolic diseases, today announced...

RSLS : 0.51 (unch)
ReShape Lifesciences Announces Third Quarter 2018 Financial Results

ReShape Lifesciences Inc. (NASDAQ: RSLS), a developer of minimally invasive medical devices to treat obesity and metabolic diseases, today reported financial results for the three months ended September...

RSLS : 0.51 (unch)
4 Healthcare Stocks Investors Should Get Familiar With

CORAL GABLES, FL / ACCESSWIRE / November 14, 2018 / The is the sector of the economy made up of companies that specialize in products and services related to health and medical care. According to reports...

IMMY : 5.83 (-2.02%)
TDOC : 51.17 (-2.44%)
RSLS : 0.51 (unch)
Today's Research Reports on Stocks to Watch: ReShape Lifesciences and ABIOMED

NEW YORK, NY / ACCESSWIRE / November 13, 2018 / It was a day of red for ReShape Lifesciences and ABIOMED on Monday. Both stocks had double digit losses despite encouraging developments reported.

ABMD : 316.19 (-1.10%)
RSLS : 0.51 (unch)
ReShape Lifesciences Completes Investigator Meeting for ReShape Vest Clinical Trial in the European Union

SAN CLEMENTE, CA ACCESSWIRE / November 12, 2018 / ReShape Lifesciences Inc. (NASDAQ: RSLS), a developer of minimally invasive medical devices to treat obesity and metabolic diseases, announced today that...

RSLS : 0.51 (unch)
ReShape Lifesciences Announces National VA Contract for ReShape Balloon

SAN CLEMENTE, CA / ACCESSWIRE / November 8, 2018 / ReShape Lifesciences Inc. (NASDAQ: RSLS), a developer of minimally invasive medical devices to treat obesity and metabolic diseases, announced today that...

RSLS : 0.51 (unch)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 72% Sell with a Weakest short term outlook on maintaining the current direction.

Longer term, the trend strength is Weak. Long term indicators fully support a continuation of the trend.

The market is in highly oversold territory. Beware of a trend reversal.

See More Share

Trade RSLS with:

Business Summary

ReShape Lifesciences Inc. is a developer of invasive medical devices to treat obesity and metabolic diseases. The company's portfolio includes vBloc System(R), ReShape(R) and Gastric Vest System (TM). ReShape Lifesciences Inc., formerly known as EnteroMedics Inc., is based in CA, United States.

See More

Key Turning Points

2nd Resistance Point 0.56
1st Resistance Point 0.54
Last Price 0.51
1st Support Level 0.49
2nd Support Level 0.46

See More

52-Week High 3,759.00
Fibonacci 61.8% 2,323.25
Fibonacci 50% 1,879.74
Fibonacci 38.2% 1,436.24
Last Price 0.51
52-Week Low 0.49

See More

Add Data Columns to this Table
Learn about our Custom Views
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Read About Upcoming
Changes to This Feature
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar